Phenotypic CRISPR screening identifies ZBTB10 as a novel regulator of human trophoblast differentiation [RNA-Seq BeWo]
RNA-seq (gene expression) · human · 12 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 12 samples: 3 × WT_DMSO vs 3 × WT_FSK vs 3 × ZBTB10KO_DMSO vs 3 × ZBTB10KO_FSKGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE336958_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1483629 and SRA study SRP713574. Searching any of these in the dataset finder brings you back here.
Supports a between-group comparison across 12 samples.
How we read this: 4 replicated groups read from 12 sample titles; they account for 12 of them. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM9845353 WT_DMSO_Rep1 WT_DMSO
- GSM9845354 WT_FSK_Rep1 WT_FSK
- GSM9845355 ZBTB10KO_DMSO_Rep1 ZBTB10KO_DMSO
- GSM9845356 ZBTB10KO_FSK_Rep1 ZBTB10KO_FSK
- GSM9845357 WT_DMSO_Rep2 WT_DMSO
- GSM9845358 WT_FSK_Rep2 WT_FSK
- GSM9845359 ZBTB10KO_DMSO_Rep2 ZBTB10KO_DMSO
- GSM9845360 ZBTB10KO_FSK_Rep2 ZBTB10KO_FSK
- GSM9845361 WT_DMSO_Rep3 WT_DMSO
- GSM9845362 WT_FSK_Rep3 WT_FSK
- GSM9845363 ZBTB10KO_DMSO_Rep3 ZBTB10KO_DMSO
- GSM9845364 ZBTB10KO_FSK_Rep3 ZBTB10KO_FSK
- GSE336960 Phenotypic CRISPR screening identifies ZBTB10 as a novel regulator of human trophoblast differentiation 22 samples shares crispr, zbtb10, trophoblast, phenotypic, identifies, screening, regulator
- GSE276052 CRISPR screening identifies regulators of enhancer mediated androgen receptor transcription in advanced prostate cancer 92 samples shares crispr, identifies, screening, regulator
- GSE275927 CRISPR screening identifies regulators of enhancer mediated androgen receptor transcription in advanced prostate cancer (ATAC-Seq) 8 samples shares crispr, identifies, screening, regulator
- GSE299089 A genome-wide CRISPR screen identifies the TNRC18 gene locus as a novel regulator of inflammatory signaling 54 samples shares crispr, identifies, regulator
- GSE301632 Genome-wide CRISPR-Cas9 knockout screening identifies NUDCD2 depletion as sensitizer for bortezomib, carfilzomib and ixazomib in multiple myeloma. 27 samples shares crispr, identifies, screening
- GSE327354 Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells [RNA-seq Exp3] 18 samples shares crispr, screening, rna-seq
- GSE261390 CRISPR Screening Uncovers a Long-Range Enhancer for ONECUT1 in Pancreatic Differentiation and Links a Diabetes Risk Variant [RNA-seq] 18 samples shares crispr, screening, rna-seq
- GSE327357 Virus-like particles enable targeted gene engineering and pooled CRISPR screening in primary human myeloid cells [RNA-Seq Exp1] 14 samples shares crispr, screening, rna-seq
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.